Quick Answer
Edwards Lifesciences Corp reported Total Assets of $13.70 billion for the year ending 2025.
- Edwards Lifesciences Corp showed an increase of +4.9% in Total Assets from 2024 to 2025.
- This data is from Edwards Lifesciences Corp's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.64 billion | Q3 2010: $1.73 billion | Q1 2011: $1.93 billion | Q2 2011: $2.00 billion | Q3 2011: $1.98 billion | Q1 2012: $2.00 billion | Q2 2012: $2.08 billion | Q3 2012: $2.20 billion | Q1 2013: $2.30 billion | Q2 2013: $2.34 billion | Q3 2013: $2.53 billion | Q1 2014: $2.65 billion | Q2 2014: $3.33 billion | Q3 2014: $3.35 billion | Q1 2015: $3.49 billion | Q2 2015: $3.61 billion | Q3 2015: $3.88 billion | Q1 2016: $3.85 billion | Q2 2016: $4.05 billion | Q3 2016: $4.34 billion | Q1 2017: $4.78 billion | Q2 2017: $5.14 billion | Q3 2017: $5.49 billion | Q1 2018: $5.83 billion | Q2 2018: $5.69 billion | Q3 2018: $5.96 billion | Q1 2019: $5.47 billion | Q2 2019: $5.57 billion | Q3 2019: $5.97 billion | Q1 2020: $6.08 billion | Q2 2020: $6.42 billion | Q3 2020: $6.80 billion | Q1 2021: $7.21 billion | Q2 2021: $7.66 billion | Q3 2021: $8.16 billion | Q1 2022: $8.42 billion | Q2 2022: $8.43 billion | Q3 2022: $8.64 billion | Q1 2023: $8.65 billion | Q2 2023: $9.00 billion | Q3 2023: $9.37 billion | Q1 2024: $9.74 billion | Q2 2024: $10.10 billion | Q3 2024: $12.97 billion | Q1 2025: $13.02 billion | Q2 2025: $13.49 billion | Q3 2025: $13.27 billion.
- Over the full 17 years of available data (2009 to 2025), Edwards Lifesciences Corp's Total Assets has grown by 747.9%.
- Historical annual values: Fiscal year 2025: $13.70 billion | Fiscal year 2024: $13.06 billion | Fiscal year 2023: $9.36 billion | Fiscal year 2022: $8.29 billion | Fiscal year 2021: $8.50 billion | Fiscal year 2020: $7.24 billion | Fiscal year 2019: $6.49 billion | Fiscal year 2018: $5.32 billion | Fiscal year 2017: $5.67 billion | Fiscal year 2016: $4.51 billion | Fiscal year 2015: $4.06 billion | Fiscal year 2014: $3.52 billion | Fiscal year 2013: $2.71 billion | Fiscal year 2012: $2.22 billion | Fiscal year 2011: $1.98 billion | Fiscal year 2010: $1.77 billion | Fiscal year 2009: $1.62 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: